Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
A new market analysis says UnitedHealth is funding an AI push and aiming for a 2-to-1 return, raising questions about execution, timelines, and how the benefits show up in results.
THE APEX TIMES
THE APEX TIMES
Pfizer (PFE) finished the latest session up 1.28% to $24.48, even as the broader market moved lower, according to the business update cited by Yahoo Finance.
THE APEX TIMES
A market report on July 13 contrasted Abbott Laboratories’ sharp year-to-date slide with Pfizer’s headline-friendly dividend yield, arguing that one stock may reflect business pressure while the other could hide slower-moving risks even after both companies topped quarterly expectations.
THE APEX TIMES
A recent market analysis notes that HCA Healthcare shares have fallen over the past six months despite gains in the broader market, prompting renewed scrutiny of the hospital operator’s post-Q1 outlook.
THE APEX TIMES
A recent options-focused market note highlighted unusual attention around HCA Healthcare shares, underscoring how derivatives markets can preview investor expectations for volatility. Details from the post were not available for this draft review.
THE APEX TIMES
The company says the study appears in The New England Journal of Medicine, extending its involvement in regenerative and genetic therapies for pediatric blood disorders.
THE APEX TIMES
A Yahoo Finance market note argues HCA Healthcare (HCA) could be trading at a large discount relative to peers following a cluster of negative catalysts, including index removals and a bank downgrade.
THE APEX TIMES
The Cambridge, Massachusetts biotech said it will report second-quarter 2026 financial results with a live call and webcast set for 8:00 a.m. ET.
THE APEX TIMES
In remarks covered a month before CVS Health reports Q2, CEO David Joyner said Aetna has a handle on medical cost trends, a message aimed at easing investor concern about insurer profitability.
